专题：HIV/AIDS drug development and treatment

This cluster of papers focuses on the efficacy and safety of antiretroviral therapy for HIV infection, including the development of drug resistance, the use of integrase inhibitors and reverse transcriptase inhibitors, and the adverse effects such as hepatotoxicity and renal toxicity. It also explores the use of nucleoside analogues for treating viral diseases.
最新文献
近5年高被引文献
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

article Full Text OpenAlex 529 FWCI37.4298

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

article Full Text OpenAlex 403 FWCI142.8607

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

article Full Text OpenAlex 275 FWCI25.6979

Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses

article Full Text OpenAlex 257 FWCI17.5679

Prolonged viral suppression with anti-HIV-1 antibody therapy

article Full Text OpenAlex 186 FWCI12.6243

Membrane transporters in drug development and as determinants of precision medicine

review Full Text OpenAlex 184 FWCI53.3835

Structure and Mechanism of Human ABC Transporters

review Full Text OpenAlex 158 FWCI36.8512

Combination anti-HIV antibodies provide sustained virological suppression

article Full Text OpenAlex 158 FWCI11.1445

Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters

review Full Text OpenAlex 155 FWCI36.1515

Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial

article Full Text OpenAlex 152 FWCI14.9713